Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 5.00 (3.45%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 145.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 18th Mar 2021 16:06

Friday 19 March 
Sanne Group PLCFull Year Results
Investec PLCTrading Statement
Johnson Service Group PLCFull Year Results
JD Wetherspoon PLCHalf Year Results
ContourGlobal PLCFull Year Results
Monday 22 March 
Blackbird PLCFull Year Results
Yew Grove REIT PLCFull Year Results
Centamin PLCFull Year Results
Kingfisher PLCFull Year Results
SDX Energy PLCFull Year Results
Tuesday 23 March 
accesso Technology Group PLCFull Year Results
Alliance Pharma PLCFull Year Results
Arrow Global Group PLCFull Year Results
Cambridge Cognition PLCFull Year Results
DP Eurasia NVFull Year Results
Elementis PLCFull Year Results
Energean PLCFull Year Results
essensys PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
H&T Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Longboat Energy PLCFull Year Results
LoopUp Group PLCFull Year Results
Luceco PLCFull Year Results
Malin Corp PLCFull Year Results
McColl's Retail Group PLCFull Year Results
MJ Hudson Group PLCHalf Year Results
Mortgage Advice Bureau Holdings PLCFull Year Results
MP Evans Group PLCFull Year Results
Old Mututal LtdFull Year Results
Personal Group Holdings PLCFull Year Results
YouGov PLCFull Year Results
Zotefoams PLCFull Year Results
Wednesday 24 March 
Softcat PLCHalf Year Results
Circassia Group PLCFull Year Results
Burford Capital LtdFull Year Results
Sopheon PLCFull Year Results
Strix Group PLCFull Year Results
TClarke PLCFull Year Results
Keywords Studios PLCFull Year Results
ECSC Group PLCFull Year Results
Telit Communications PLCFull Year Results
Bellway PLCHalf Year Results
Diploma PLCTrading Statement
Anglo Pacific Group PLCFull Year Results
Frontier IP Group PLCHalf Year Results
Pendragon PLCFull Year Results
Applied Graphene Materials PLCHalf Year Results
Kenmare Resources PLCFull Year Results
Thursday 25 March 
Allied Minds PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Biome Technologies PLCFull Year Results
Cineworld Group PLCFull Year Results
Compass Group PLCTrading Statement
CVS Group PLCHalf Year Results
EnQuest PLCFull Year Results
Equiniti Group PLCFull Year Results
Faron Pharmaceuticals OyFull Year Results
Funding Circle Holdings PLCFull Year Results
Genedrive PLCHalf Year Results
International Public Partnerships LtdFull Year Results
IQE PLCFull Year Results
Lamprell PLCFull Year Results
Learning Technologies Group PLCFull Year Results
Pebble Group PLCFull Year Results
Robinson PLCFull Year Results
S4 Capital PLCFull Year Results
Safestyle UK PLCFull Year Results
SIG PLCFull Year Results
Surgical Innovations Group PLCFull Year Results
United Utilities Group PLCTrading Statement
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 May 2020 10:37

Faron Pharmaceuticals confirms publication of 'crucial' study

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that the results of its detailed analyses into the effects of glucocorticoids on intravenous interferon beta-1a activity, which arose following the 'INTEREST' trial in 2018, had been published in critical care journal Intensive Care Medicine.

Read more
11 May 2020 16:48

Faron Pharma Gets EUR800,000 Grant From Finnish Cancer Consortium

Faron Pharma Gets EUR800,000 Grant From Finnish Cancer Consortium

Read more
11 May 2020 16:03

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
5 May 2020 12:05

Faron Pharmaceuticals Picks Manufacturing Partner For Clevegen Therapy

Faron Pharmaceuticals Picks Manufacturing Partner For Clevegen Therapy

Read more
5 May 2020 09:20

Faron Pharmaceuticals inks manufacturing deal with AGC Biologics

(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has selected contract development and manufacturing organisation AGC Biologics as the commercial-scale manufacturer of 'Clevegen', it announced on Tuesday.

Read more
27 Apr 2020 13:52

UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director

UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director

Read more
27 Apr 2020 13:51

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

Read more
22 Apr 2020 18:42

Faron Raises EUR14 Million In Oversubscribed Share Placing

Faron Raises EUR14 Million In Oversubscribed Share Placing

Read more
21 Apr 2020 18:21

Faron Pharmaceuticals Plans Private Placing To Raise EUR10 Million

Faron Pharmaceuticals Plans Private Placing To Raise EUR10 Million

Read more
1 Apr 2020 17:56

UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work

UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work

Read more
20 Mar 2020 11:25

Research And Development Expense Drop Cuts Faron Pharmaceuticals Loss

Research And Development Expense Drop Cuts Faron Pharmaceuticals Loss

Read more
20 Mar 2020 10:49

UK WINNERS & LOSERS SUMMARY: Future Surges As It Sees Results In Line

UK WINNERS & LOSERS SUMMARY: Future Surges As It Sees Results In Line

Read more
13 Mar 2020 16:04

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
9 Mar 2020 14:07

Faron Pharmaceuticals Gets Green Light For New Traumakine Trial

Faron Pharmaceuticals Gets Green Light For New Traumakine Trial

Read more
9 Mar 2020 10:26

Faron gets FDA tick from proposed design of next 'Traumakine' study

(Sharecast News) - Faron Pharmaceuticals announced on Monday that the US Food and Drug Administration (FDA) has accepted its proposed protocol design for the next 'Traumakine' study in acute respiratory distress syndrome (ARDS) patients, following its protocol submission in February.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.